University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Generating EQ-5D-5L health utility scores from BASDAI and BASFI : a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data

dc.contributor.authorNeilson, Aileen R.
dc.contributor.authorJones, Gareth T.
dc.contributor.authorMacfarlane, Gary J.
dc.contributor.authorPathan, Ejaz M.
dc.contributor.authorMcNamee, Paul
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Health Economics Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.date.accessioned2023-01-06T00:10:47Z
dc.date.available2023-01-06T00:10:47Z
dc.date.issued2022-11
dc.descriptionAcknowledgements We are grateful to the staff of the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis. Claudia Zabke, Maureen Heddle, Nafeesa Nazlee and Barry Morris, and to the recruiting staff at the clinical centres, details of which are available at: https://www.abdn.ac.uk/iahs/research/epidemiology/spondyloarthritis.php#panel1011. Funding The British Society for Rheumatology Biologics Register in Ankylosing. Spondylitis (BSRBR-AS) is funded by the British Society for Rheumatology (BSR), which in turn has received funding from the manufacturers of the biologic therapies included in the study (Abbvie, Pfizer and UCB). Pharmaceutical companies providing funds to BSR do not have a role in the oversight of the study, but they do receive advance notice of publications on which they can comment. They do not have access to the data collected but can request analyses of the data, for which additional funds are provided.en
dc.description.statusPeer revieweden
dc.format.extent13
dc.format.extent1313199
dc.identifier211299583
dc.identifier5d32ddfc-78fe-4ded-bc56-8195e24b3db6
dc.identifier000750742700001
dc.identifier000750742700001
dc.identifier85124194848
dc.identifier.citationNeilson, A R, Jones, G T, Macfarlane, G J, Pathan, E M & McNamee, P 2022, 'Generating EQ-5D-5L health utility scores from BASDAI and BASFI : a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data', European Journal of Health Economics, vol. 23, pp. 1357-1369. https://doi.org/10.1007/s10198-022-01429-xen
dc.identifier.doi10.1007/s10198-022-01429-x
dc.identifier.issn1618-7598
dc.identifier.otherORCID: /0000-0003-0016-7591/work/106160785
dc.identifier.otherORCID: /0000-0003-2322-3314/work/106161205
dc.identifier.urihttps://hdl.handle.net/2164/19802
dc.identifier.vol23en
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Health Economicsen
dc.subjectmixture modelsen
dc.subjectutility mappingen
dc.subjectresponse mappingen
dc.subjectEQ-5D-5Len
dc.subjectBASDAI/BASFIen
dc.subjectaxial spondyloarthritisen
dc.subjectR Medicineen
dc.subjectOtheren
dc.subjectBSRBR-ASen
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleGenerating EQ-5D-5L health utility scores from BASDAI and BASFI : a mapping study in patients with axial spondyloarthritis using longitudinal UK registry dataen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Neilson_etal_EJHE_EQ_5D_5L_VOR.pdf
Size:
1.25 MB
Format:
Adobe Portable Document Format

Collections